HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) in Upper-middle income (World Bank)
Upper-middle income (World Bank): HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) was 84.0% in 2014. ▼ Falling
HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) in Upper-middle income (World Bank), 2003–2014
Source: World Health Organization, Global Health Observatory.
Analysis
In 2014, hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) in Upper-middle income (World Bank) stood at 84.0%.
Compared with earlier readings it is up 2.4% on the previous year and down 16.0% over ten years.
Over the whole period, hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) in Upper-middle income (World Bank) peaked at 100.0% in 2004 and was at its lowest, 62.0%, in 2007.
The long-run direction has been consistently falling across the 12 years of available data.
HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) in Upper-middle income (World Bank), year by year
| Year | Value | Change |
|---|---|---|
| 2003 | 95.0% | — |
| 2004 | 100.0% | +5.3% |
| 2005 | 100.0% | +0.0% |
| 2006 | 94.0% | -6.0% |
| 2007 | 62.0% | -34.0% |
| 2008 | 70.0% | +12.9% |
| 2009 | 69.0% | -1.4% |
| 2010 | 73.0% | +5.8% |
| 2011 | 76.0% | +4.1% |
| 2012 | 78.0% | +2.6% |
| 2013 | 82.0% | +5.1% |
| 2014 | 84.0% | +2.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 84.3% | 62.0% | 100.0% | 7 |
| 2010s | 78.6% | 73.0% | 84.0% | 5 |
More health data for Upper-middle income (World Bank)
- Measles - number of reported cases, gaps filled 91,627 (2025)
- Diphtheria - number of reported cases, gaps filled 1,556 (2025)
- Total tetanus - number of reported cases, gaps filled 5,773 (2025)
- Pertussis - number of reported cases, gaps filled 63,803 (2025)
- Neonatal tetanus - number of reported cases, gaps filled 212 (2025)
- Number of under-five deaths, annual growth rate -6.19 % change on previous year (2024)
- Number of neonatal deaths, annual growth rate -4.24 % change on previous year (2024)
- Number of infant deaths, annual growth rate -4.78 % change on previous year (2024)
- Measles - number of reported cases, annual growth rate -27.52 % change on previous year (2025)
- Pertussis - number of reported cases, annual growth rate -87.69 % change on previous year (2025)
Frequently asked questions
- What is hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) in Upper-middle income (World Bank)?
- Hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) in Upper-middle income (World Bank) was 84.0% in 2014, according to World Health Organization, Global Health Observatory.
- What is the highest hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) recorded in Upper-middle income (World Bank)?
- The highest recorded value was 100.0% in 2004.
- What is the lowest hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) recorded in Upper-middle income (World Bank)?
- The lowest recorded value was 62.0% in 2007.
- How does Upper-middle income (World Bank) rank for hiv-positive tb patients on cpt (co-trimoxazole preventive therapy)?
- Upper-middle income (World Bank) ranks 6th out of 11 groups with data for 2014.
- Is hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) rising or falling in Upper-middle income (World Bank)?
- Over the last ten years it is down 16.0%. The long-run trend across the full record is falling.
- Where does this Upper-middle income (World Bank) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 12 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).